AM
Alpheus Medical, Inc.
SEC filingBiotechnology · Chanhassen, MN
Amount raised$60.5Msold at filing
Total offering$67M$6.5M still open
Investors in the raise22count reported to the SEC
FiledJul 30, 2026first sale May 2, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jeremy LingExecutive Officer
Robert SteinDirector
Vijay AgarwalExecutive Officer, Director
John JohnsonDirector
Klaus VeitingerDirector
Peter ThompsonDirector
Imran EbaExecutive Officer
Steve WeinerExecutive Officer
Juan-Pablo MasDirector
Executive officers, directors and promoters as listed on the Form D.